Skip to main content

Share story

Capital

LawVu Raises $11.9M in Series

LawVu Raises $11.9M in Series Image: Primary
LawVu has secured 11.9 million dollars in its latest funding round. The capital will support ongoing development and expansion initiatives for the company. LawVu offers a platform that centralizes legal operations for in-house teams. The system enables workload management, collaboration with internal stakeholders, and streamlined processes. It connects legal departments with the broader organization to improve communication and workflow. LawVu plans to use the funds to accelerate its product development roadmap. The company will also expand its market reach and scale operations to meet demand. Specific allocation details were not disclosed.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from SignalBase and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital Infrastructure
Capital Infrastructure

Zero Infinity Partners announces $156 million infrastructure technology fund

Zero Infinity Partners announced $156 million in commitments for its second fund, which will invest in early-stage companies applying technology to physical infrastructure. The firm said the fund is 50% larger than its predecessor...

Infrastructure Capital
Infrastructure Capital

Clastix raises €2.9 million for Kubernetes infrastructure software

Italian infrastructure software company Clastix has raised €2.9 million in its first external funding round, led by CDP Venture Capital with participation from Mistral and Vertis SGR. Clastix plans to use the seed capital for prod...

Products Capital
Products Capital

Databricks acquires spreadsheet startup Row Zero

Databricks announced Thursday that it has acquired Row Zero, a startup whose cloud spreadsheet handles more than 1 million live rows. Its finance team had been using Row Zero alongside Genie, Databricks' AI agent for asking questi...

Capital Products
Capital Products

City Therapeutics files for initial public offering

City Therapeutics filed a registration statement for an initial public offering of its common stock on September 24. The clinical-stage biotechnology company has applied to list on the Nasdaq Global Market under the symbol CTY. It...